NCT02752698

Brief Summary

Central South University in collaboration with Tianjin University developed the first domestically produced Chinese minimally invasive surgical (MIS) robot system which named "Micro Hand S" in 2013. Recently, as the domestic surgical robot research project's main section, this new MIS robot had been authorized to enter the clinical trial stage by the Ethics Committee of the Third Xiangya Hospital at Central South University.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 15, 2015

Completed
11 months until next milestone

First Posted

Study publicly available on registry

April 27, 2016

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

April 1, 2021

Status Verified

March 1, 2021

Enrollment Period

7 years

First QC Date

June 15, 2015

Last Update Submit

March 29, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • intraoperative outcomes

    surgical procedure/operative time/console time/blood loss/conversion

    up to 1 week after operation

  • postoperative outcomes

    Time to first flatus/intake/hospital stay

    up to 1 month after operation

  • pathological outcomes

    resection margin/harvested lymph node/mesorectal grade

    up to 1 month after operation

  • complication

    type of complication/grade of complication

    within 30 days after surgery

Secondary Outcomes (4)

  • functional outcomes

    at least12 months after operation

  • recurrence

    at least 12 months after operation

  • survival

    at least 12 months yesra after operation

  • change of blood and biochemiacl

    within 1 month after operation

Study Arms (3)

Micro Hand S robotic group

EXPERIMENTAL

Micro Hand S robotic surgery group

Procedure: Micro Hand S robotic surgery

laparoscopic surgery

OTHER

laparoscopic surgery group

Procedure: laparoscopic surgery

da Vinci robotic group

OTHER

da Vinci robotic robotic group

Procedure: da Vinci robotic surgery

Interventions

20-70 patients undergo Micro Hand S robotic surgeries

Micro Hand S robotic group

20-70 patients undergo laparoscopic surgeries

laparoscopic surgery

20-70 patients undergo da Vinci robotic surgeries

da Vinci robotic group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of gastric tumor, colorectal tumor, acute cholecystitis and ileocecal tumor respectively
  • years\<age\<65years
  • male or female

You may not qualify if:

  • patients with a history of open abdominal surgery
  • unstable psychiatric illness
  • an inability or reluctance to cooperate during long-term follow-up
  • alcohol or drug addiction
  • or relatively high surgical risks, such as abnormal coagulation function or bad heart, lung, liver and kidney function, were excluded from this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Third Xiangya Hospital of Central South University

Changsha, Hunan, 410013, China

Location

Related Publications (2)

  • Lei Y, Jiang J, Zhu S, Yi B, Li J. Comparison of the short-term efficacy of two types of robotic total mesorectal excision for rectal cancer. Tech Coloproctol. 2022 Jan;26(1):19-28. doi: 10.1007/s10151-021-02546-0. Epub 2021 Nov 30.

  • Zeng Y, Wang G, Li Z, Lin H, Zhu S, Yi B. The Micro Hand S vs. da Vinci Surgical Robot-Assisted Surgery on Total Mesorectal Excision: Short-Term Outcomes Using Propensity Score Matching Analysis. Front Surg. 2021 May 11;8:656270. doi: 10.3389/fsurg.2021.656270. eCollection 2021.

MeSH Terms

Conditions

Colonic NeoplasmsCholecystolithiasisAppendicitisStomach NeoplasmsRectal Neoplasms

Interventions

Laparoscopy

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesCholelithiasisBiliary Tract DiseasesGallbladder DiseasesIntraabdominal InfectionsInfectionsGastroenteritisCecal DiseasesStomach DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • shaihong zhu, MD

    The Third Xiangya Hospital of Central South University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2015

First Posted

April 27, 2016

Study Start

January 1, 2015

Primary Completion

December 30, 2021

Study Completion

December 30, 2021

Last Updated

April 1, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations